The Tongo-Test is Russia’s first noninvasive rapid test for the diagnosis of migraine by the level of CGRP in tear fluid. The result is in 10 minutes, without laboratory equipment. It allows you to objectively confirm the diagnosis and select targeted therapy (monoclonal antibodies against CGRP). RF Patent No. 2838426. Sensitivity >95%, specificity 97%.